Literature DB >> 17721689

Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.

Hiroshi Ouchi1, Masaki Fujita, Satoshi Ikegame, Ichiro Inoshima, Eiji Harada, Yoichi Nakanishi.   

Abstract

A 63-year-old man was admitted to our hospital because he complained of fever and productive cough; this was associated with cavitary infiltrates on his chest X-ray. Although several antibiotics were given, his symptoms did not improve. Bronchofiberscope investigation yielded Aspergillus fumigatus; thus, he was diagnosed with chronic necrotizing pulmonary aspergillosis. Itraconazole, 200 mg/day, was given, and his symptoms and infiltrates on chest X-ray gradually improved. After 2 months of treatment, new infiltrates appeared on a chest X-ray. Antibacterial agents had also shown no effect, and voriconazole was substituted for itraconazole. However, the infiltrates progressed in spite of the voriconazole administration. We added micafungin to the voriconazole treatment. Both his symptoms and the infiltrates on chest X-rays improved. Because voriconazole is thought to be the most effective agent against Aspergillus spp., it is difficult to treat cases that are refractory to voriconazole. The treatment of this case provides invaluable information on how to treat pulmonary aspergillosis related to diseases other than hematologic malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721689     DOI: 10.1007/s10156-007-0524-9

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Progressive increase in cavitation with the evolution of fungus ball: A clue to the diagnosis of chronic necrotizing pulmonary aspergillosis.

Authors:  R Prasad; Sanjay R Garg
Journal:  Lung India       Date:  2009-07

2.  Chronic Pulmonary Aspergillosis Infection in Coal Workers Pneumoconiosis With Progressive Massive Fibrosis.

Authors:  Avinash Vangara; Mythili Gudipati; Regina Chan; Tuong Vi Do; Omrao Bawa; Subramanya Shyam Ganti
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 3.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.